Omega-3 effects on viral infectionsRationale and design of the pragmatic randomized trial of icosapent ethyl for high cardiovascular risk adults (MITIGATE).
Most Relevant Research
We examined the MITIGATE study, focusing on the effects of icosapent ethyl (IPE), a purified omega-3 fatty acid, in adults with cardiovascular disease at risk for viral upper respiratory infections.
With about 16,500 participants, this clinical trial compared IPE treatment against usual care. The goal was to see if IPE could lessen the severity and impact of viral infections over six months.
Unfortunately, there was no significant evidence found that IPE improved outcomes for upper respiratory infections in this group.
No more sinusitis
Most Useful Review
I’ve been taking this Omega-3 for a year and a half, and I find it exceptional. The optimal EPA and DPA ratio, along with vitamin D, means I have not caught a cold in over a year! Although I was exposed to the virus, my body managed to cope without developing a full-blown illness. Remarkably, I no longer suffer from sinusitis, which had troubled me for ten years. This change feels miraculous, and I’m thrilled with the results, including rapid hair growth.